(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Multiple Endocrine Neoplasia Type 1 D018761 2 associated lipids
HIV Wasting Syndrome D019247 3 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Basal Ganglia Cerebrovascular Disease D020144 1 associated lipids
Epilepsy, Reflex D020195 5 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Heredodegenerative Disorders, Nervous System D020271 1 associated lipids
Intracranial Hemorrhages D020300 2 associated lipids
Median Neuropathy D020423 1 associated lipids
Ulnar Neuropathies D020424 1 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Matković M et al. Synthesis of novel adamantyl and homoadamantyl-substituted β-hydroxybutyric acids. 2013 Mol. Divers. pmid:24043584
Zebeli Q et al. Intermittently-induced endotoxaemia has no effect on post-challenge plasma metabolites, but increases body temperature and cortisol concentrations in periparturient dairy cows. 2013 Res. Vet. Sci. pmid:23911054
Sørensen LK et al. Simultaneous determination of β-hydroxybutyrate and β-hydroxy-β-methylbutyrate in human whole blood using hydrophilic interaction liquid chromatography electrospray tandem mass spectrometry. 2013 Clin. Biochem. pmid:23994603
Yuan K et al. TNFα altered inflammatory responses, impaired health and productivity, but did not affect glucose or lipid metabolism in early-lactation dairy cows. 2013 PLoS ONE pmid:24260367
Fanos V et al. Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation. 2013 Early Hum. Dev. pmid:23809353
Ospina PA et al. Using nonesterified fatty acids and β-hydroxybutyrate concentrations during the transition period for herd-level monitoring of increased risk of disease and decreased reproductive and milking performance. 2013 Vet. Clin. North Am. Food Anim. Pract. pmid:23809897
El-Deeb WM Clinicobiochemical investigations of gangrenous mastitis in does: immunological responses and oxidative stress biomarkers. 2013 J Zhejiang Univ Sci B pmid:23303629
Xu J et al. Metabolomic profilings of urine and serum from high fat-fed rats via 1H NMR spectroscopy and pattern recognition. 2013 Appl. Biochem. Biotechnol. pmid:23306893
Hughes TE et al. Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women. 2013 Obesity (Silver Spring) pmid:23512440
Haviland JA et al. NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment. 2013 Obesity (Silver Spring) pmid:23512955